Literature DB >> 7755486

Expression of clusterin (testosterone-repressed prostate message-2) mRNA during growth and regeneration of rat liver.

W Bursch1, T Gleeson, L Kleine, M Tenniswood.   

Abstract

Clusterin has been used as a marker for apoptosis (often denoted "active" "or programmed" cell death) in the prostate, mammary gland and other solid organs. The protein is thought to be involved in membrane remodelling during separation of apoptotic cells from their vital neighbours and fragmentation into apoptotic bodies. In the present study, we have looked at the expression of clusterin during the growth and regression of rat liver induced by short term administration of the hepatomitogen, cyproterone acetate. The steady state level of clusterin mRNA, as measured by Northern and slot blot analysis, is low in control hepatocytes. Following administration of cyproterone acetate, the clusterin mRNA level is increased during both liver growth and regression. In situ hybridization reveals that clusterin is expressed in all hepatocytes, indicating that it is not confined to cell death by apoptosis. These results suggest that the gene product may be involved in maintaining membrane integrity, which is necessary during both mitosis and apoptosis. To determine whether clusterin mRNA is induced by membrane remodelling independent of either mitosis or apoptosis, we examined the expression of clusterin mRNA in the liver after a necrogenic dose of carbon tetrachloride. During the first 24-48 h of this time period, necrosis is the predominant form of cell death and liver regeneration starts after approximately 24 h. Elevated levels of clusterin mRNA are found as early as 12 h after carbon tetrachloride administration and persist for at least 72 h.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7755486     DOI: 10.1007/s002040050167

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  29 in total

Review 1.  Active cell death in hormone-dependent tissues.

Authors:  M P Tenniswood; R S Guenette; J Lakins; M Mooibroek; P Wong; J E Welsh
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

Review 2.  The biochemistry of cell death by apoptosis.

Authors:  W Bursch; L Kleine; M Tenniswood
Journal:  Biochem Cell Biol       Date:  1990-09       Impact factor: 3.626

Review 3.  Programmed cell death: new thoughts and relevance to aging.

Authors:  R A Lockshin; Z F Zakeri
Journal:  J Gerontol       Date:  1990-09

4.  Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: identity to sulfated glycoprotein 2, a constituent of rat testis fluid.

Authors:  D E Jenne; J Tschopp
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

Review 5.  Clusterin: the intriguing guises of a widely expressed glycoprotein.

Authors:  D E Jenne; J Tschopp
Journal:  Trends Biochem Sci       Date:  1992-04       Impact factor: 13.807

Review 6.  Cell death: the significance of apoptosis.

Authors:  A H Wyllie; J F Kerr; A R Currie
Journal:  Int Rev Cytol       Date:  1980

7.  Genomic organization and expression of the rat TRPM-2 (clusterin) gene, a gene implicated in apoptosis.

Authors:  P Wong; J Pineault; J Lakins; D Taillefer; J Léger; C Wang; M Tenniswood
Journal:  J Biol Chem       Date:  1993-03-05       Impact factor: 5.157

8.  Purification and characterization of a sulfated glycoprotein secreted by Sertoli cells.

Authors:  M D Griswold; K Roberts; P Bishop
Journal:  Biochemistry       Date:  1986-11-18       Impact factor: 3.162

9.  Apolipoprotein J: structure and tissue distribution.

Authors:  H V de Silva; J A Harmony; W D Stuart; C M Gil; J Robbins
Journal:  Biochemistry       Date:  1990-06-05       Impact factor: 3.162

10.  Kinetic studies on a murine sarcoma and an analysis of apoptosis.

Authors:  C E Sarraf; I D Bowen
Journal:  Br J Cancer       Date:  1986-12       Impact factor: 7.640

View more
  2 in total

1.  Overexpression of clusterin in human breast carcinoma.

Authors:  M Redondo; E Villar; J Torres-Muñoz; T Tellez; M Morell; C K Petito
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Clusterin silencing sensitizes pancreatic cancer MIA-PaCa-2 cells to gmcitabine via regulation of NF-kB/Bcl-2 signaling.

Authors:  Miao Xu; Xiumei Chen; Yanling Han; Chunqing Ma; Lin Ma; Shirong Li
Journal:  Int J Clin Exp Med       Date:  2015-08-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.